Paxlovid: antiviral combination for the treatment of COVID‐19
Sign Up to like & getrecommendations! Published in 2022 at "Prescriber"
DOI: 10.1002/psb.1979
Abstract: Paxlovid (nirmatrelvir/ritonavir) is an oral antiviral combination for the treatment of COVID‐19 in adults at risk of progression to severe disease. This article summarises its indications, interactions and efficacy. read more here.
Keywords: treatment covid; antiviral combination; combination treatment;